1
Philippe Leboulch, Eric Bouhassira, Karen Westerman, Ken Julian Takekoshi: Methods and compositions for transforming cells. Albert Einstein College of Medicine of Yeshiva University a Division of Yeshiva University, Massachusetts Institute of Technology, Jane E Remillard Esq, Lahive & Cockfield, July 27, 1999: US05928914 (50 worldwide citation)

Methods and compositions for transforming cells, resulting in efficient and stable site-specific integration of transgenes, are disclosed. Transformation is achieved by introducing into a cell an acceptor vector, preferably a retroviral vector, which integrates into the genome of the cell. The accep ...


2
Eric Bouhassira, Philippe Leboulch: Methods and compositions for transforming cells. Massachusetts Institute of Technology, Jane E Remillard Esq, Richa Nand Esq, Lahive & Cockfield, March 18, 2003: US06534314 (3 worldwide citation)

Methods and compositions for transforming cells, resulting in efficient and stable site-specific integration of transgenes, are disclosed. Transformation is achieved by providing an acceptor DNA containing two inverted lox sequences and a donor DNA containing the same two inverted lox sequences, and ...


3

4
Bouhassira Eric, Leboulch Philippe: Methods and compositions for transforming cells using site-specific recombination. Massachusetts Institute of Technology, Albert Einstein College Of Medicine Of Yeshiva University, Bouhassira Eric, Leboulch Philippe, REMILLARD Jane E, October 26, 2000: WO/2000/063410

Methods and compositions for transforming cells, resulting in efficient and stable site-specific integration of transgenes, are disclosed. Transformation is achieved by providing an acceptor DNA containing two inverted lox sequences and a donor DNA containing the same two inverted lox sequences, and ...


5
Leboulch Philippe, Bouhassira Eric, Westerman Karen, Takekoshi Ken Julian: Methods and compositions for transforming cells. Massachusetts Institute of Technology, Albert Einstein College Of Medecine Of Yeshiva University, REMILLARD Jane E, December 18, 1997: WO/1997/047758

Methods and compositions for transforming cells, resulting in efficient and stable site-specific integration of transgenes, are disclosed. Transformation is achieved by introducing into a cell an acceptor vector, preferably a retroviral vector, which integrates into the genome of the cell. The accep ...


6
Leboulch Philippe, Bouhassira Eric, Westerman Karen, Takekoshi Ken Julian: Methods and compositions for transforming cells. Massachusetts Inst Technology, Einstein Coll Med, May 12, 1999: EP0914457-A1

Methods and compositions for transforming cells, resulting in efficient and stable site-specific integration of transgenes, are disclosed. Transformation is achieved by introducing into a cell an acceptor vector, preferably a retroviral vector, which integrates into the genome of the cell. The accep ...


7

8
HYBRID PROTEINS AND USES THEREOF. April 13, 2017: US20170101652-A1

There are disclosed hybrid proteins comprising at least one signal sequence; at least one DNA binding domain; and at least one cell penetrating peptide (CPP) domain. In embodiments the CPP domain is a TAT domain, and the DNA binding domain is a HU domain. There is also disclosed the use of the hybri ...